Primary Site >> Colorectal Cancer
Gene >> BCR
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Acquisition of Philadelphia chromosome with bcr rearrangement concomitant with transformation of refractory anemia with excess of blasts with 8 trisomy into acute myelogenous leukemia]. PMID: 2366338 |
Ref: T-cell immunity to oncogenic proteins including mutated ras and chimeric bcr-abl. PMID: 8103658 |
Ref: Evaluation of clinical indexes to predict fate of pelvic nerve dysfunction. PMID: 9840340 |
Ref: Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571. PMID: 14726674 |
Ref: Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. PMID: 15912532 Ref: Bcr is a negative regulator of the Wnt signalling pathway. PMID: 16211085 |
Ref: [Molecular markers in hematology and oncology]. PMID: 20859878 Ref: PMID: 26065050 |
Ref: Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients. PMID: 21128281 |
Ref: Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. PMID: 23637631 Ref: The chromatin remodelling component SMARCB1/INI1 influences the metastatic behavior of colorectal cancer through a gene signature mapping to chromosome 22. PMID: 24286138 Ref: B cell regulation of anti-tumor immune response. PMID: 24293009 |
Ref: [Genome sequencing and personalized medicine: perspectives and limitations]. PMID: 26259290 |
Ref: Correction: Out of the blue finger ischaemia and occult colorectal cancer PMID: 28275022 |
Ref: Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer. PMID: 29438985 |